Your session is about to expire
← Back to Search
Lidocaine 5% patch for Lower Back Pain
Phase 4
Waitlist Available
Research Sponsored by Cook County Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week and 1 month
Awards & highlights
Study Summary
This study will evaluate the addition of lidocaine % transdermal patches to standard therapy in the treatment of acute non-radicular low back pain in patients discharged from the Emergency Department. In addition to standard therapy, half of the participants will receive medicated patches while the other half will receive non-medicated patches.
Eligible Conditions
- Lower Back Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 week and 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week and 1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Pain
Roland-Morris-24 back pain disability scale
Other outcome measures
Repeat visits
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Lidocaine 5% patchExperimental Treatment2 Interventions
Patients will receive a 7 day supply (21 patches) of lidocaine 5% patches upon discharge from the emergency department in addition to "standard therapy" at the discretion of the treating emergency department physician.
Group II: Non-medicated patchActive Control2 Interventions
Patients will receive a 7 day supply (21 patches) of non-medicated patches upon discharge from the emergency department in addition to "standard therapy" at the discretion of the treating emergency department physician.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
standard therapy
2016
Completed Phase 3
~1200
Find a Location
Who is running the clinical trial?
Cook County HealthLead Sponsor
46 Previous Clinical Trials
16,195 Total Patients Enrolled
John H. Stroger HospitalLead Sponsor
42 Previous Clinical Trials
13,125 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger